DEF 14A: GRI Bio Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance

GRI Bio is asking stockholders to approve a reverse stock split to meet Nasdaq's minimum bid price requirement and avoid potential delisting.

Summary

• GRI Bio is holding a special meeting of stockholders on February 11, 2025, to vote on two proposals.
• The first proposal is to approve an amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio of not less than 1-for-2 and not more than 1-for-23.
• The exact ratio will be determined by the board of directors.
• The second proposal is to approve the adjournment of the special meeting to a later date if necessary to permit further solicitation of proxies if there are not sufficient votes in favor of the first proposal.
• The company's board of directors recommends voting for both proposals.
• The reverse stock split is intended to help the company regain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
• On September 10, 2024, GRI Bio received a letter from Nasdaq stating that it no longer met this requirement.
• The company has until March 10, 2025, to regain compliance.
• If the reverse stock split is approved and implemented, the number of outstanding shares will decrease, potentially increasing the stock price.
• The amendment would not change the par value of the common stock or the total number of authorized shares.
• As of January 6, 2025, the closing price for GRI Bio's common stock was $0.832 per share.
• As of the record date, January 6, 2025, there were 8,933,366 shares of common stock outstanding.
• The company intends to raise capital through additional issuances of equity securities.
• The company has retained Campaign Management, LLC as its proxy solicitor for a fee of $8,500, plus reasonable expenses.

Sentiment

Score: 5

Explanation: The document presents a neutral view, outlining the need for a reverse stock split to maintain Nasdaq compliance. While the action itself can be viewed negatively, the document focuses on the procedural aspects and potential benefits, without overly optimistic or pessimistic language.

Positives

• The reverse stock split could increase the market price of the common stock, helping the company regain compliance with Nasdaq listing requirements.
• The company is taking proactive steps to address the Nasdaq minimum bid price deficiency.
• The board of directors has the flexibility to abandon the reverse stock split if it is not in the best interests of the company.
• The reverse stock split will not change the total number of authorized shares, providing flexibility for future capital raising activities.

Negatives

• Reverse stock splits can have a negative perception among investors.
• The stock prices of some companies that have effected reverse stock splits have subsequently declined.
• There is no guarantee that the reverse stock split will increase the stock price or maintain compliance with Nasdaq listing requirements.
• If the company is delisted from Nasdaq, trading of its common stock would be conducted on the OTC Markets or the pink sheets, making it more difficult for investors to dispose of their shares.
• The company may need to obtain substantial additional funding in connection with its continuing operations, and there is no assurance that such financing will be available when needed.

Risks

• The reverse stock split may not be successful in increasing the stock price or maintaining Nasdaq listing compliance.
• The company may be delisted from Nasdaq if it does not regain compliance with the minimum bid price requirement.
• Delisting could make it more difficult for investors to trade the company's stock.
• The company's ability to raise additional capital could be adversely affected if it is delisted.
• The company's need for additional funding may not be met, which could force it to reduce spending, delay development programs, or cease operations entirely.
• The issuance of additional shares could dilute existing stockholders and cause a decline in the trading price of the common stock.

Future Outlook

The company intends to raise capital through additional issuances of equity securities and/or short-term or long-term debt arrangements.

Management Comments

• The board of directors believes that if the number of shares of our common stock cast at the Special Meeting is insufficient to approve the Amendment Proposal, it is in the best interests of our stockholders to enable our board of directors to continue to seek to obtain a sufficient number of additional votes to approve the Amendment Proposal.

Industry Context

Many companies facing similar circumstances, such as potential delisting due to low stock prices, consider reverse stock splits as a means to regain compliance with exchange listing requirements.

Comparison to Industry Standards

• Reverse stock splits are a relatively common strategy for companies facing delisting from exchanges like Nasdaq due to low share prices.
• Other companies in the biotechnology or pharmaceutical industries that have implemented reverse stock splits include [hypothetical company 1] and [hypothetical company 2].
• The success of a reverse stock split in maintaining listing and improving investor perception varies widely and depends on the company's underlying financial health and future prospects.

Stakeholder Impact

• The reverse stock split could impact shareholders by potentially increasing the stock price, but also carries the risk of further decline.
• Employees may be affected by the company's ability to raise capital and continue operations.
• The company's suppliers and creditors could be impacted if the company is forced to reduce spending or delay payments.

Next Steps

• Stockholders will vote on the proposals at the Special Meeting on February 11, 2025.
• If approved, the board of directors will decide whether and when to implement the reverse stock split.
• The company will file a Form 8-K to announce the final voting results.

Key Dates

Keywords

reverse stock split, Nasdaq, minimum bid price, compliance, delisting, proxy statement, stockholders, amendment, common stock, capital raising